Publication | Open Access
Comparisons between tumor burden and other prognostic factors that influence survival of patients with non‐small cell lung cancer treated with immune checkpoint inhibitors
27
Citations
26
References
2019
Year
TB is a useful, clinically measurable prognostic factor of survival in NSCLC patients treated with ICIs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1